Class information for:
Level 3: MULTIPLE MYELOMA//AMYLOIDOSIS//THALIDOMIDE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
398 27726 31.9 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 4)


ID, lev.
above		 Publications Label for level above
6 1383009 IMMUNOLOGY//TRANSPLANTATION//ALLERGY

Classes in level below (level 2)


ID, lev.
below		 Publications Label for level below
605 13295 MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA
1211 8738 AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
1820 5693 HAPTOGLOBIN//PENTRAXIN 3//PTX3

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 MULTIPLE MYELOMA Author keyword 2244 49% 12% 3307
2 AMYLOIDOSIS Author keyword 1084 56% 5% 1335
3 THALIDOMIDE Author keyword 863 59% 4% 973
4 TRANSTHYRETIN Author keyword 701 65% 2% 670
5 AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS Journal 592 69% 2% 512
6 MYELOMA Author keyword 474 45% 3% 792
7 AL AMYLOIDOSIS Author keyword 364 85% 1% 194
8 FAMILIAL AMYLOIDOTIC POLYNEUROPATHY Author keyword 347 88% 1% 165
9 LENALIDOMIDE Author keyword 329 55% 1% 413
10 PLASMACYTOMA Author keyword 283 60% 1% 313

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class		 LCSH search Wikipedia search
1 MULTIPLE MYELOMA 2244 49% 12% 3307 Search MULTIPLE+MYELOMA Search MULTIPLE+MYELOMA
2 AMYLOIDOSIS 1084 56% 5% 1335 Search AMYLOIDOSIS Search AMYLOIDOSIS
3 THALIDOMIDE 863 59% 4% 973 Search THALIDOMIDE Search THALIDOMIDE
4 TRANSTHYRETIN 701 65% 2% 670 Search TRANSTHYRETIN Search TRANSTHYRETIN
5 MYELOMA 474 45% 3% 792 Search MYELOMA Search MYELOMA
6 AL AMYLOIDOSIS 364 85% 1% 194 Search AL+AMYLOIDOSIS Search AL+AMYLOIDOSIS
7 FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 347 88% 1% 165 Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY Search FAMILIAL+AMYLOIDOTIC+POLYNEUROPATHY
8 LENALIDOMIDE 329 55% 1% 413 Search LENALIDOMIDE Search LENALIDOMIDE
9 PLASMACYTOMA 283 60% 1% 313 Search PLASMACYTOMA Search PLASMACYTOMA
10 HAPTOGLOBIN 261 48% 1% 404 Search HAPTOGLOBIN Search HAPTOGLOBIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of publ.
in class
1 PRIMARY SYSTEMIC AMYLOIDOSIS 888 81% 2% 534
2 AL AMYLOIDOSIS 758 81% 2% 459
3 SYSTEMIC AMYLOIDOSIS 709 71% 2% 571
4 MULTIPLE MYELOMA 505 20% 8% 2301
5 NEWLY DIAGNOSED MYELOMA 492 87% 1% 241
6 LENALIDOMIDE PLUS DEXAMETHASONE 460 80% 1% 284
7 LIGHT CHAIN AMYLOIDOSIS 389 80% 1% 245
8 MONOCLONAL GAMMOPATHY 386 46% 2% 624
9 SAA 312 78% 1% 207
10 PRE ALBUMIN 307 78% 1% 200

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS 592 69% 2% 512
2 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 42 26% 1% 141
3 CLINICAL LYMPHOMA & MYELOMA 35 30% 0% 97
4 CLINICAL LYMPHOMA 6 19% 0% 26
5 BLOOD CANCER JOURNAL 5 14% 0% 32

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
MEDICAL PROGRESS Multiple Myeloma 2011 407 80 91%
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma 2009 323 26 96%
Current treatment landscape for relapsed and/or refractory multiple myeloma 2015 4 82 90%
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review 2009 275 80 95%
Drug therapy: Multiple myeloma 2004 729 84 82%
Multiple myeloma 2009 258 113 94%
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders 2009 237 34 100%
IMWG consensus on risk stratification in multiple myeloma 2014 28 64 94%
Genetics of multiple myeloma: another heterogeneity level? 2015 3 60 92%
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management 2010 170 21 100%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMYLOID TREATMENT PROGRAM 268 96% 0.3% 86
2 AMYLOIDOSIS 171 72% 0.5% 133
3 MYELOMA THER Y 154 55% 0.7% 193
4 AMYLOIDOSIS TREATMENT 109 84% 0.2% 59
5 JEROME LIPPER MULTIPLE MYELOMA 102 54% 0.5% 133
6 MYELOMA UNIT 87 72% 0.2% 68
7 AMYLOID UNIT 85 92% 0.1% 34
8 BING WALDENSTROMS MACROGLOBULINEMIA 63 77% 0.2% 43
9 HUMAN IMMUNOL CANC PROGRAM 49 69% 0.2% 42
10 HEMATOL INTERNAL MED 40 26% 0.5% 133

Related classes at same level (level 3)


Rank Relatedness score Related classes
1 0.0000002047 HEMATOLOGY//LEUKEMIA & LYMPHOMA//HEMATOL
2 0.0000001918 EXPERIMENTAL HEMATOLOGY//THROMBOPOIETIN//JOURNAL OF INTERFERON RESEARCH
3 0.0000001485 COMPLEMENT//JOURNAL OF IMMUNOLOGY//COMMON VARIABLE IMMUNODEFICIENCY
4 0.0000001292 MYASTHENIA GRAVIS//GUILLAIN BARRE SYNDROME//THYMOMA
5 0.0000001210 BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
6 0.0000001163 AUTOPHAGY//TRAIL//APOPTOSIS
7 0.0000001005 CHRONIC GRANULOMATOUS DISEASE//RAMADAN//RAMADAN FASTING
8 0.0000000972 JOURNAL OF IMMUNOLOGY//IMMUNOL//DENDRITIC CELLS
9 0.0000000966 LANGERHANS CELL HISTIOCYTOSIS//AUTOIMMUNE PANCREATITIS//INFLAMMATORY PSEUDOTUMOR
10 0.0000000911 UROLOGY & NEPHROLOGY//PERITONEAL DIALYSIS INTERNATIONAL//NEPHROL